Article

Low back pain recommended/actual care gap is hurting patients

Key aspects of the usual care that general practitioners provide for patients with low back pain (LBP) do not align with the care recommended in evidence-based guidelines. The likely result is less than optimal outcomes.

Key aspects of the usual care that general practitioners provide for patients with low back pain (LBP) do not align with the care recommended in evidence-based guidelines. The likely result is less than optimal outcomes.

Williams and associates compared actual care of patients with LBP against international “best practice” guidelines. Care provided during 3533 patient visits in Australia was mapped to key recommendations in the published guidelines.

Discrepancies between recommended and actual LBP treatment were observed on several fronts. Contrary to recommendations against imaging, general practitioners sent about 25% of their patients for imaging studies. Where the guidelines call for education and advice as first-line intervention for LBP, only about 20% of patients reported receiving counseling. Although the guidelines call for treatment with simple analgesics-acetaminophen-to control pain, 37.4% of patients received NSAIDs; 19.6% received opioid analgesics; and only 17.7% received acetaminophen, mostly at a dosage other than the recommended 4 g/d.

The authors noted that given that usual care is the control treatment in many trials of new treatments for patients with LBP, these trials may provide overly optimistic estimates of the effects of the new therapy.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.